HR Advanced Breast Cancer Introduction Restaging at Relapse vs De Novo Metastatic Disease Visceral Crisis Personalizing Endocrine Therapy Endocrine Therapy Landscape FIRST Trial Fulvestrant vs Anastrozole ID: 703708
Download Presentation The PPT/PDF document "The Nurse View: Hormone Receptor-Positi..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
The Nurse View: Hormone Receptor-Positive Advanced Breast CancerSlide2Slide3
HR+ Advanced Breast CancerIntroductionSlide4
Restaging at Relapse vs De Novo Metastatic DiseaseSlide5
Visceral CrisisSlide6
Personalizing Endocrine TherapySlide7
Endocrine Therapy LandscapeSlide8
FIRST TrialFulvestrant vs AnastrozoleSlide9
FIRST Trial -- SafetySlide10
FALCON: Anastrozole vs Fulvestrant in HR+ Advanced or Metastatic Breast Cancer Slide11
FALCONMost Common AEs (> 5%)Slide12
Aromatase InhibitorsManagement of AEsSlide13
HOPE StudyExercise AdherenceSlide14
Overcoming Endocrine Resistance in MBCSlide15
PALOMA-2 Palbociclib + Letrozole vs Letrozole Alone Slide16
PALOMA-2AE SummarySlide17
Palbociclib Dosing and Drug InteractionSlide18
PalbociclibManagement of Hematological ToxicitiesSlide19
MONALEESA-2: Ribociclib + Letrozole vs Letrozole in HR+ Advanced Breast Cancer Slide20
MONALEESA-2Safety ProfileSlide21
Managing Treatment-Related Adverse Events from CDK InhibitorsSlide22
BOLERO-2 Everolimus + Exemestane vs Placebo + Exemestane Slide23
BOLERO-2Most Common Grade 3/4 Adverse EventsSlide24
SWISH Trial Dexamethasone-Based Mouthwash for StomatitisSlide25
Management Issues With EverolimusSlide26
PALOMA-3Palbociclib + Fulvestrant in Pre/Perimenopausal M
BCSlide27
PALOMA-3 Safety ResultsSlide28
Educating our patientsSlide29
Managing Adherence to Oral TherapySlide30
Specific Measures To Manage PatientsSlide31
Concluding RemarksSlide32
AbbreviationsSlide33
Abbreviations (cont)